Publications by authors named "Marius Witt"

Claim this Profile
E
Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction.
Marius Witt, Leticia Oliveira-Ferrer, Friedrich Koch-Nolte, Stephan Menzel, Louisa Hell

Oncoimmunology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine Regulatory CD4 T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT.
Julius Krüger, Jasmin Wellbrock, Marius Witt, Niklas Kruppa, Jana Muschhammer

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIGIT blockade repolarizes AML-associated TIGIT M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis.
Franziska Brauneck, Brit Fischer, Marius Witt, Jana Muschhammer, Jennyfer Oelrich

J Immunother Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases.
Melanie Albrecht, Olga Halle, Svenja Gaedcke, Sophia T Pallenberg, Julia Camargo Neumann, Marius Witt

Clin Transl Immunology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer.
Pauline Weimer, Jasmin Wellbrock, Tabea Sturmheit, Leticia Oliveira-Ferrer, Yi Ding, Marius Witt

Cells· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis